Literature DB >> 19766634

Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets.

Ruqaiyyah Siddiqui1, Edward L Jarroll, Naveed Ahmed Khan.   

Abstract

Balamuthia mandrillaris is a causative agent of granulomatous encephalitis that almost always proves fatal. A major concern during the course of therapy is that B. mandrillaris can transform into cysts. Cysts are highly resistant to physical and chemical conditions and present a problem in successful antimicrobial chemotherapy. However, the underlying mechanisms of B. mandrillaris transformation into cysts are not known. In this study, we examined the effects of exogenous sugars on B. mandrillaris encystment. The findings revealed that free exogenous galactose, but not other sugars, enhanced parasite differentiation into cysts, and apparently a galactose-binding protein is involved in B. mandrillaris encystment. Cytoskeletal re-arrangements and phosphatidylinositol 3-kinase (PI3K)-mediated pathways are involved in B. mandrillaris encystment based on inhibitor studies. Dual functionality of galactose-binding protein in B. mandrillaris pathogenesis and encystment is discussed further. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766634     DOI: 10.1016/j.exppara.2009.09.013

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

Review 1.  Cellular, biochemical, and molecular changes during encystment of free-living amoebae.

Authors:  Emilie Fouque; Marie-Cécile Trouilhé; Vincent Thomas; Philippe Hartemann; Marie-Hélène Rodier; Yann Héchard
Journal:  Eukaryot Cell       Date:  2012-02-24

2.  The effect of environmental and physiological conditions on excystation of Acanthamoeba castellanii belonging to the T4 genotype.

Authors:  Sahreena Lakhundi; Naveed Ahmed Khan; Ruqaiyyah Siddiqui
Journal:  Parasitol Res       Date:  2014-05-16       Impact factor: 2.289

3.  Actin, RhoA, and Rab11 participation during encystment in Entamoeba invadens.

Authors:  M Herrera-Martínez; V I Hernández-Ramírez; A E Lagunes-Guillén; B Chávez-Munguía; P Talamás-Rohana
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

4.  Metabolic profiling of the protozoan parasite Entamoeba invadens revealed activation of unpredicted pathway during encystation.

Authors:  Ghulam Jeelani; Dan Sato; Afzal Husain; Aleyla Escueta-de Cadiz; Masahiro Sugimoto; Tomoyoshi Soga; Makoto Suematsu; Tomoyoshi Nozaki
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Balamuthia mandrillaris: Morphology, biology, and virulence.

Authors:  Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Trop Parasitol       Date:  2015 Jan-Jun

6.  The effects of phosphanegold(I) thiolates on the biological properties of Acanthamoeba castellanii belonging to the T4 genotype.

Authors:  Ruqaiyyah Siddiqui; Farhat Abjani; Chien Ing Yeo; Edward R T Tiekink; Naveed Ahmed Khan
Journal:  J Negat Results Biomed       Date:  2017-04-03

7.  Whole Organism Model to Study Molecular Mechanisms of Differentiation and Dedifferentiation.

Authors:  Areeba Anwar; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Biology (Basel)       Date:  2020-04-17

8.  Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris.

Authors:  Matthew T Laurie; Corin V White; Hanna Retallack; Wesley Wu; Matthew S Moser; Judy A Sakanari; Kenny Ang; Christopher Wilson; Michelle R Arkin; Joseph L DeRisi
Journal:  mBio       Date:  2018-10-30       Impact factor: 7.867

9.  Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity.

Authors:  Gretchen Ehrenkaufer; Pengyang Li; Erin E Stebbins; Monica M Kangussu-Marcolino; Anjan Debnath; Corin V White; Matthew S Moser; Joseph DeRisi; Jolyn Gisselberg; Ellen Yeh; Steven C Wang; Ana Hervella Company; Ludovica Monti; Conor R Caffrey; Christopher D Huston; Bo Wang; Upinder Singh
Journal:  PLoS Negl Trop Dis       Date:  2020-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.